Navigation Links
Gastrointestinal Disorders Therapeutics to 2016 - High Unmet Needs Triggering Strong Growth in Crohn's Disease and Irritable Bowel Syndrome Markets Now Available at ReportsandReports
Date:6/28/2010

Table 66: Irritable Bowel Syndrome Therapeutics Market, Global, Diagnosis Population, 2009-2016 51

Table 67: Irritable Bowel Syndrome Therapeutics Market, Global, Prescription Population, 2001-2009 52

Table 68: Irritable Bowel Syndrome Therapeutics Market, Global, Prescription Population, 2009-2016 52

Table 69: Irritable Bowel Syndrome Therapeutics Market, Global, Usage Patterns, 2001-2009 53

Table 70: Irritable Bowel Syndrome Therapeutics Market, Global, Usage Patterns, 2009-2016 54

Table 71: Ulcerative Colitis Therapeutics Market, Global, Revenue ($m), 2001-2009 58

Table 72: Ulcerative Colitis Therapeutics Market, Global, Revenue ($m), 2009-2016 58

Table 73: Ulcerative Colitis Therapeutics Market, Global, Annual Cost of Treatment , 2001-2009 59

Table 74: Ulcerative Colitis Therapeutics Market, Global, Annual Cost of Treatment , 2009-2016 59

Table 75: Ulcerative Colitis Therapeutics Market, Global, Diseased Population, 2001-2009 60

Table 76: Ulcerative Colitis Therapeutics Market, Global, Diseased Population, 2009-2016 60

Table 77: Ulcerative Colitis Therapeutics Market, Global, Treatment Seeking Population, 2001-2009 61

Table 78: Ulcerative Colitis Therapeutics Market, Global, Treatment Seeking Population, 2009-2016 61

Table 79: Ulcerative Colitis Therapeutics Market, Global, Diagnosis Population, 2001-2009 62

Table 80: Ulcerative Colitis Therapeutics Market, Global, Diagnosis Population, 2009-2016 62

Table 81: U
'/>"/>

SOURCE MarketsandMarkets
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26

Related biology technology :

1. Shire Expands its Gastrointestinal Portfolio Through In-Licensing Celiac Disease Phase 2 Product From Alba Therapeutics Corporation
2. ViroPharma Provides Update on Upcoming FDA Advisory Committee Meeting to Discuss Bioequivalence of Locally Acting Gastrointestinal Drugs
3. Gleevec Receives FDA Priority Review as First Therapy to Reduce Recurrence of Gastrointestinal Stromal Tumors After Surgery
4. DOR BioPharma Receives FDA Orphan Drug Designation for orBec(R) for the Treatment of Chronic Gastrointestinal GVHD
5. Soligenix Announces Grant of Broad European Patent for Topically Active Steroids to Treat Inflammatory Gastrointestinal Disorders
6. New Study Showed the Impact of Gastrointestinal Disorders in Patients With Parkinsons Disease
7. Pfizer and Bristol-Myers Squibb Finalize Agreement for Worldwide Collaboration on Metabolic Disorders Program
8. TAP Pharmaceutical Products Inc. Files New Drug Application for TAK-390MR in Patients with Acid-Related Disorders
9. Synosia Announces Encouraging Results of Proof-of-Concept Clinical Trial for Epilepsy Drug rufinamide as a Treatment for Mood Disorders
10. SleepQuest Raises Awareness of Sleep Disorders
11. S*BIO Receives Orphan Drug Designation for JAK2 Inhibitor SB1518 for the Treatment of Myeloproliferative Disorders
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2015)... DALLAS , July 30, 2015  With over 60,000 customers across the globe, ISN ... helps connect 450 hiring organizations with more than 60,000 safe and reliable contractors in over 80 ... ... ... Headquartered in Dallas, ...
(Date:7/30/2015)... 30, 2015  Discovery Laboratories, Inc. (Nasdaq: ... the second $1.0M tranche under a previously awarded ... valued at up to $3.0 million to support ... as a potential medical countermeasure to mitigate acute ... awarded an initial $1.0 million under this grant ...
(Date:7/29/2015)... Sanofi, a global and ... quarter of 2015. CEO Olivier Brandicourt ... in different businesses. Watch video interview ... Topics covered in the interview include:  ... Performance drivers - Diabetes ...
(Date:7/29/2015)... 29, 2015 US-Australian drug discovery company, Novogen ... it is committed to progressing its ground-breaking technology platforms ... and to ensure the Company delivers the best value ... Iain Ross , said the Company currently had an ... programs, discovery programs and academic partnerships and initiatives, and ...
Breaking Biology Technology:ISN Reaches Over 60,000 Worldwide Customers 2ISN Reaches Over 60,000 Worldwide Customers 3Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 2Discovery Labs Receives $1.0 million under an SBIR Grant in Continuing Support of the Development of Aerosolized KL4 Surfactant to Address Radiation-Induced Lung Injury 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10
... Berkley Life Sciences, LLC, a,member company of ... LS Prime. LS Prime is a uniquely innovative ... faced by life,science companies of all sizes., ... errors and omissions, and premises operations coverages. Included,with ...
... ... Radiesse, SAN MATEO, Calif., June 26 BioForm Medical,Inc. ... studies in the,June 2008 issue of the Journal of Dermatologic ... The five,published clinical and preclinical reports were:, -- A ...
... 26 /Xinhua-PRNewswire-FirstCall/ --,China-Biotics, Inc. (OTC Bulletin ... Chinese firm specializing in the manufacture,research, ... products,today announced it signed a one-year ... ("Lijia") to supply probiotics for Lijia,s,probiotics-based ...
Cached Biology Technology:Berkley Life Sciences Introduces LS Prime: A Revolutionary New Primary Liability Policy for the Life Science Industry 2Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers 2Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers 3Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers 4Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers 5Radiesse(R) Dermal Filler Featured Prominently in Journal of Dermatologic Surgery Special Issue on Fillers 6China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company 2China-Biotics, Inc. to Supply Probiotics to Pharmaceutical Company 3
(Date:7/23/2015)... Research and Markets ( http://www.researchandmarkets.com/research/rzzp3v/global_outlook_of ) ... Outlook of the Biometrics Industry 2015 " ... global biometrics market is likely to witness significant ... to the uptake of multiple technologies available. The ... the growth of biometrics in existing applications as ...
(Date:7/13/2015)... 2015 Synaptics Inc. (NASDAQ: SYNA ... today announced sampling of ClearPad ® 4300, ... (TDDI) product targeting smartphones and tablets. This new ... , best-in-class touch controller IP and systems ... in the company,s Japan Design Center. TDDI enables ...
(Date:7/9/2015)... , July 9, 2015  Synaptics ... developer of human interface solutions, today announced ... industry,s first fully hardware encapsulated fingerprint sensor ... authentication technology is literally off the grid, ... biometric matching within the fingerprint sensor to ...
Breaking Biology News(10 mins):Global Outlook of the Biometrics Industry 2015 2Global Outlook of the Biometrics Industry 2015 3Synaptics Announces Sampling of Second Generation TDDI Solutions 2Synaptics Announces Sampling of Second Generation TDDI Solutions 3Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 2Synaptics Announces World's First Match-in-Sensor Fingerprint Authentication Technology 3
... DALLAS Oct. 17, 2008 A single molecule in ... bacteria, plays a large role in controlling whether the host ... from UT Southwestern Medical Center, has found in a mouse ... food through the intestine, allowing the animal to absorb more ...
... California Institute of Technology (Caltech) have created a "plug-and-play" ... is capable of taking in and responding to more ... In the future, such devices could have a ... sensors to sniff out tumor cells or determine when ...
... -- The discovery of a protein involved in the ... at the Florida State University College of Medicine attract ... Health. Branko Stefanovic, associate professor in the department ... his discovery could lead to treatment methods that may ...
Cached Biology News:Waste from gut bacteria helps host control weight, UT Southwestern researchers report 2Caltech engineers build firast-ever multi-input 'plug-and-play' synthetic RNA device 2FSU researcher's discovery leads to $1.5 million grant, potential new treatment of liver fibrosis 2
Rabbit polyclonal to Warfarin ( Abpromise for all tested applications). Antigen: Chemical / Small Molecule conjugated to KLH...
HSD17B3 Immunogen: HSD17B3 (NP_000188, 29 a.a. ~ 120 a.a) partial recombinant protein with GST tag. Storage: -20 C, Avoid Freeze/Thaw Cycles *Available for distribution in the US only...
Rabbit polyclonal to 13,14 dihydro 15 keto Prostaglandin E2 ( Abpromise for all tested applications)....
Goat polyclonal to T7 tag (Agarose) Immunogen: Goats were immunized with MASMTGGQQMG (T7) conjugated to KLH.After multiple immunizations in Freund's adjuvant, serum was collected....
Biology Products: